Form 4/A for VKTX Viking Therapeutics, Inc.
Accepted 2025-04-08 00:00:00 ET · period of report 2025-03-31 · accession 0000950170-25-052255 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2025-04-08 | 2025-03-31 | VKTX | Rouan Sarah Kathryn | Dir | P - Purchase | $24.15 | +1,240 | 1,240 | New | +$29.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.00001 per share | 2025-03-31 | P | A | 1,240 | $24.15 | 1,240 | D | — | — |